L1 - Intro Flashcards
Aetiology
cause, set of causes, or manner of causation of a disease
Pathogenesis
Origination and development of a disease
Obstructive conditions
Reduction in airflow
difficult to exhale so air remains in lungs following full expiration
Obstructive causes
this occurs due to inflammation, excess mucus and airway narrowing via smooth muscle tightening
Restrictive conditions
reduction in lung volume
hard to inhale lungs as they cannot fully expand
Restrictive causes
lung scarring, fibrosis and extra-parenchymal problems
Infections, environmental and other diseases
viral and bacterial infections, asbestosis, particulate pollutants
vascular diseases
pulmonary oedema, pulmonary hypertension
Environmental influences
around 11,000 litres of air enter our lungs everydaty
Inhalational exposures
allergens, microbes, aerosolised toxins i.e. tobacco smoke and air pollutants
genetic influence
mono or polygenic diseases
Monogenic diseases
rare diseases attributable to genetic variants with large effects
Cystric fibrosis protein
CFTR
CFTR function
Cl- ion transport
CFTR mutation
autosomal recessive
Alpha-1-antitrypsin deficiency protein
SERPINA1
SERPINA1 function
serine protease inhibitor
SERPINA1 mutation
autosomal recessive
Kartagener’s syndrome symptom
immotile cilia
Kartagener’s syndrome protein
DNA1
DNA1 function
dynein arm with ciliary function
DNA1 mutation
autosomal recessive
Hereditary Pulmonary Arterial Hypertension protein
BMPR2
BMPR2 function
BMP-signalling
BMPR2 mutation effects
endothelial dysfunction and smooth muscle proliferation
BMPR2 mutation
autosomal dominant
Chronic Granulomatous disease protein
CYBB
CYBB function
component of phagocyte oxidase complex
CYBB mutation
autosomal recessive
Polygenic disease
complex diseases controlled by 2 or more genes at different loci on different chromosomes
TLR2/4 and CD14
Pathogen recognition and innate immunity
IL10 and TGFB1
Anti-inflammatory
IL4 and IL4R
Th2 responses and IgE production
IL13
Mucus production and IgE production
IL2R and IL18R
T cell proliferation and Th1 responses
TNFA
Proinflammatory
ADAM 33
airway remodelling and airway hyperresponsiveness
GSTP1, GSTM1 and SOD3
Antioxidants